Review Article
Adipose-Derived Stem Cells for Tissue Engineering and Regenerative Medicine Applications
Table 5
List of clinical trials using ASCs.
| Condition | Number | Phase | Study design | Study type | Reference |
| Breast reconstruction | 2 | Phase 2 | ASCs enriched fat graft | Interventional | NCT01771913 | Phase 4 | Autologous SVFs | Interventional | NCT00616135 |
| Lipoatrophy | 1 | Phase 1 | SVF-enriched fat graft | Interventional | NCT01828723 |
| Fistula | 6 | Phase 1/Phase 2 | Allogenic ASCs | Interventional | NCT01372969; NCT00999115 | Phase 1 | Autologous ASCs | Interventional | NCT00992485 | Phase 2 | Autologous ASCs | Interventional | NCT01011244 | Phase 3 | Autologous ASCs | Interventional | NCT00475410 | Prospective | Autologous ASCs | Observational | NCT01020825 |
| Liver cirrhosis | 1 | | Autologous ASCs | Interventional | NCT01062750 |
|
Cardiovascular disease |
4 | Phase 1 | Autologous SVFs | Interventional | NCT00442806; NCT00426868 | Phase 2 | Autologous ASCs | Interventional | NCT01449032; NCT01216995 |
| Peripheral vascular diseases and cardiovascular diseases | 1 | Phase 1/Phase 2 | Autologous SVFs | Interventional | NCT01211028 |
| Urinary incontinence | 1 | Phase 2 | Autologous ASCs | Interventional | NCT01799694 |
| Localized adverse reaction to administration of drug | 1 | Phase 1 | Allogenic ASCs | Interventional | NCT01743222 |
| Osteoarthritis | 2 | Phase 1 | Autologous ASCs |
Interventional | NCT01585857 | Phase 1/Phase 2 | Autologous ASCs | Interventional | NCT01809769 |
| Buerger’s disease | 1 | Phase 1/Phase 2 | Autologous ASCs | Interventional | NCT01302015 |
| Brain injury | 1 | Phase 1/Phase 2 | Autologous ASCs | Interventional | NCT01649700 |
| Cerebellar ataxia | 1 | Phase 1/Phase 2 | Allogenic ASCs | Interventional | NCT01649687 |
| Spinal cord injury | 2 | Phase 1 | Autologous ASCs | Interventional | NCT01274975; NCT01624779 |
| Soft tissue mass removal | 1 | | SVFs | Interventional | NCT01399307 |
| Diabetic foot ulcer | 1 | Phase 1 | Allogenic ASCs | Interventional | NCT02394886 |
| Limb ischemia | 2 | Phase 1/Phase 2 | Autologous ASCs | Interventional | NCT01257776; NCT01663376 |
| Overweight | 1 | Prospective | Bone Grafts using ASCs and different scaffolds | Observational | NCT01218945 |
| Rheumatoid arthritis | 1 | Phase 1/Phase 2 | Allogenic ASCs | Interventional | NCT01663116 |
| Degenerative arthritis | 1 | Phase 1/Phase 2 | Autologous ASCs | Interventional | NCT01300598 |
| Sepsis | 1 | Phase 1 | Allogenic ASCs | Interventional | NCT02328612 |
| Romberg’s disease | 1 | Phase 2 | Autologous ASCs | Interventional | NCT01309061 |
| Depressed scar | 1 | Phase 2/Phase 3 | Autologous ASCs | Interventional | NCT00992147 |
| Healthy | 1 | Phase 1 | Allogenic ASCs | Interventional | NCT01739530 |
|
|
ASCs, adipose-derived stem cells; SVFs, stromal vascular fraction.
|